AI-Driven Drug Clinical Trials by Year End, Says Google’s Hassabis

SS: One of the most potentially impactful areas of AI application, drug design and personalised medicine, may be fast becoming a bigger reality in the coming years. AI and machine-learning has the potential to massively speed up the discovery of new therapeutic compounds, with newer projects such as [AlphaFold3](https://www.nature.com/articles/s41586-024-07487-w) able to accurately predict the shape of proteins orders of magnitudes faster and with less compute than older brute-force projects such as [Folding@home](https://foldingathome.org/). With clinical trials for drugs discovered using these tools potentially scheduled for this year, progress may begin to accelerate further as more interest and funding pours into the field.

But you need an administration that is willing to accept ya know…science.